European Medical Solutions's quarterly market cap
increased
from Jun. 2023 (€23.83 Mil) to Dec. 2023 (€35.01 Mil) but then
declined
from Dec. 2023 (€35.01 Mil) to Jun. 2024 (€29.50 Mil).
European Medical Solutions's annual market cap
increased
from Dec. 2021 (€4.89 Mil) to Dec. 2022 (€82.83 Mil) but then
declined
from Dec. 2022 (€82.83 Mil) to Dec. 2023 (€35.01 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. European Medical Solutions's Enterprise Value for Today is €38.25 Mil.
European Medical Solutions Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of European Medical Solutions's Market Cap
For the Biotechnology subindustry, European Medical Solutions's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
European Medical Solutions's Market Cap Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, European Medical Solutions's Market Cap distribution charts can be found below:
* The bar in red indicates where European Medical Solutions's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
European Medical Solutions (XBRU:ALEMS) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
European Medical Solutions Market Cap Related Terms
Thank you for viewing the detailed overview of European Medical Solutions's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
European Medical Solutions Formerly DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XBRU:ALEMS has been successfully added to your 